The "Monoclonal Antibody Therapeutics: From Analytics to Formulation Excellence" virtual masterclass offers a comprehensive exploration of this critical field in biopharmaceuticals. Over three intensive half-day sessions, participants will delve into cutting-edge advancements shaping the future of antibody-based therapies. This course covers innovative analytical methods, state-of-the-art formulation strategies, and crucial regulatory considerations, providing a holistic view of the complex challenges and opportunities in monoclonal antibody development and characterization.
Led by the distinguished Prof. Dr. Tudor Arvinte, a pioneer in protein formulation with over three decades of industry experience, this course bridges the gap between academic research and practical application. Participants will gain invaluable insights into innovative techniques developed by Therapeomic, examine historical trends in antibody formulations, and explore real-world case studies of both marketed antibodies and those in development.
From cutting-edge spectroscopy methods to high-throughput analysis platforms, this masterclass covers a wide spectrum of topics crucial for anyone working in the rapidly evolving field of antibody therapeutics. Whether you're involved in research and development, quality control, or regulatory affairs, this course offers a unique opportunity to enhance your expertise and stay at the forefront of this dynamic industry.
By combining theoretical knowledge with practical examples and interactive Q&A sessions, this masterclass provides a holistic view of the challenges and opportunities in monoclonal antibody formulation and characterization. Join us to gain the insights and skills needed to drive innovation in this critical area of modern medicine.
This introduction provides a broader overview of the course, highlighting its comprehensive nature, the expertise of the instructor, and the relevance of the content to various professionals in the field. It also emphasizes the balance between theoretical knowledge and practical application, which should appeal to a wide range of potential participants.
Key Highlights
Led by the distinguished Prof. Dr. Tudor Arvinte, a pioneer in protein formulation with over three decades of industry experience, this course bridges the gap between academic research and practical application. Participants will gain invaluable insights into innovative techniques developed by Therapeomic, examine historical trends in antibody formulations, and explore real-world case studies of both marketed antibodies and those in development.
From cutting-edge spectroscopy methods to high-throughput analysis platforms, this masterclass covers a wide spectrum of topics crucial for anyone working in the rapidly evolving field of antibody therapeutics. Whether you're involved in research and development, quality control, or regulatory affairs, this course offers a unique opportunity to enhance your expertise and stay at the forefront of this dynamic industry.
By combining theoretical knowledge with practical examples and interactive Q&A sessions, this masterclass provides a holistic view of the challenges and opportunities in monoclonal antibody formulation and characterization. Join us to gain the insights and skills needed to drive innovation in this critical area of modern medicine.
This introduction provides a broader overview of the course, highlighting its comprehensive nature, the expertise of the instructor, and the relevance of the content to various professionals in the field. It also emphasizes the balance between theoretical knowledge and practical application, which should appeal to a wide range of potential participants.
Key Highlights
- Explore new analytical methods developed by Therapeomic for characterizing antibody therapeutics
- Gain insight into the diversity of aggregates and particulates in antibody formulations
- Learn about high-throughput analysis and formulation techniques
- Review antibody formulations from 1955-2023 and examine case studies of marketed antibodies
- Understand the importance of formulation in antibody product development
- Discover approaches for developing biosimilar antibody products
- Examine the characterization of antibody interactions with human plasma and blood
